Key facts
- Notable investors include Pear (California), Bling Capital, Max Ventures, Fundamental Ventures, Greenpoint Capital — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for Atrix AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Atrix AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Atrix AI
Developer of a medical insights platform designed to transform raw data into actionable insights to improve patient outcomes and clinical opportunities. The company's platform uses AI to enrich and connect siloed data across various functions like a healthcare-grade generative AI model, a proprietary database of performant content, and a compliant experimentation engine, enabling medical affairs teams to identify unmet needs, optimize resource allocation, and drive real-world impact.
- Sector
- Information Technology
- HQ
- Covina, CA, United States
- Founded
- 2023
- Employees
- 4
- Website
- atrix.ai/
- Ownership
- Privately Held (backing)
Atrix AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Atrix AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Atrix AI in its N-PORT filings yet. We sweep new filings monthly.